StockNews.com began coverage on shares of NantHealth (NASDAQ:NH – Free Report) in a report published on Tuesday morning. The brokerage issued a hold rating on the stock.
NantHealth Stock Performance
NH opened at $0.39 on Tuesday. NantHealth has a fifty-two week low of $1.24 and a fifty-two week high of $9.75. The company has a market capitalization of $2.98 million, a P/E ratio of -0.05 and a beta of 1.82. The stock has a fifty day moving average of $0.39 and a 200-day moving average of $0.39.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. Susquehanna International Group LLP bought a new position in NantHealth in the first quarter valued at about $25,000. Goldman Sachs Group Inc. bought a new position in NantHealth in the second quarter valued at about $36,000. Millennium Management LLC bought a new position in NantHealth in the second quarter valued at about $110,000. Finally, Atria Wealth Solutions Inc. bought a new position in NantHealth in the first quarter valued at about $170,000. Institutional investors own 4.50% of the company’s stock.
About NantHealth
NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.
Recommended Stories
- Five stocks we like better than NantHealth
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Comprehensive Analysis of PayPal Stock
- Why Invest in High-Yield Dividend Stocks?
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.